Mood Management Versus Mood Tolerance in Alcohol Treatment04/01/2000 - 03/31/2004 (Co-PI)
NIH/National Institute on Alcohol Abuse and Alcoholism5 R03 AA12210 02
Clinical Research Sites for the NIAAA Medications Development Clinical Investigations Network for the Treatment of Alcohol Use Disorder03/15/2021 - 03/14/2025 (PI)
National Institute of Child Health and Human Development/NIH/DHHS
NCIG-7 NIAAA Randomized, Double Blind, Placebo-Controlled Trial of the Efficacy of Intranasal Oxytocin for the Treatment of Alcohol Use Disorder02/17/2022 - 01/29/2024 (Subcontract PI)
PI:
Eric G. Devine, PhDFast Track Drugs and Biologics NIH NIAAA
The Effects of the Histamine-3 Receptor Inverse Agonist Pitolisant on Alcohol Self-Administration in Heavy Drinkers09/20/2020 - 08/30/2023 (PI)
National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS1R21AA028864-01
The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers09/01/2019 - 08/31/2021 (PI)
National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS5R21AA027332-02
R21 - Lacosamide effects on alcohol self administration and craving in heavy drinkers09/01/2018 - 08/31/2021 (PI)
National Institute on Alcohol Abuse and Alcoholism/NIH/DHHS5R21AA026389-02
Wearable Noninvasive Blood Alcohol Monitor08/01/2019 - 09/30/2020 (Subcontract PI)
PI:
Eric G. Devine, PhDKWJ Engineering, Inc. NIH NIAAA2R44AA024651-02
Phase 2, Multi-Center Trial of Lorcaserin in the Treatment of Cocaine Use Disorder04/01/2017 - 04/30/2019 (PI)
National Institute on Drug Abuse/NIH/DHHS
NCIG-007 CLINICAL STUDY10/01/2017 - 02/28/2018 (Subcontract PI)
PI:
Eric G. Devine, PhDFast Track Drugs and Biologics NIH NIAAA
NCIG-006, Randomized, Double Blind, Placebo-Controlled Trial of the Safety and Efficacy of …04/01/2015 - 09/19/2017 (PI)
Fast Track Drugs and Biologics NIH-NIAAA